pentobarbital will lower the extent or outcome of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will decrease the extent or influence of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.pentobarbital will lessen the level or result of capivas